SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/22 – ‘R2’

On:  Monday, 8/8/22, at 4:01pm ET   ·   For:  6/30/22   ·   Accession #:  950170-22-15497   ·   File #:  1-35547

Previous ‘10-Q’:  ‘10-Q’ on 5/9/22 for 3/31/22   ·   Next & Latest:  ‘10-Q’ on 11/7/22 for 9/30/22   ·   1 Reference:  To:  Veradigm Inc. – ‘8-K’ on 5/5/22 for 5/2/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/08/22  Allscripts Healthcare Soluti… Inc 10-Q        6/30/22  104:19M                                    Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   5.02M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     32K 
10: R1          Document and Entity Information                     HTML     84K 
11: R2          Consolidated Balance Sheets (Unaudited)             HTML    167K 
12: R3          Consolidated Balance Sheets (Unaudited)             HTML     57K 
                (Parenthetical)                                                  
13: R4          Consolidated Statements of Operations (Unaudited)   HTML    160K 
14: R5          Consolidated Statements of Comprehensive Income     HTML     66K 
                (Loss) (Unaudited)                                               
15: R6          Consolidated Statements of Stockholders' Equity     HTML    158K 
                (Unaudited)                                                      
16: R7          Consolidated Statements of Stockholders Equity      HTML     31K 
                (Parenthetical)                                                  
17: R8          Consolidated Statements of Cash Flows (Unaudited)   HTML    150K 
18: R9          Basis of Presentation and Significant Accounting    HTML     45K 
                Policies                                                         
19: R10         Revenue from Contracts with Customers               HTML    215K 
20: R11         Accounts Receivable                                 HTML     54K 
21: R12         Leases                                              HTML    136K 
22: R13         Business Combinations and Divestitures              HTML     89K 
23: R14         Fair Value Measurements and Long-term Investments   HTML    187K 
24: R15         Stockholders' Equity                                HTML    155K 
25: R16         Earnings (Loss) Per Share                           HTML    233K 
26: R17         Goodwill and Intangible Assets                      HTML    162K 
27: R18         Debt                                                HTML    210K 
28: R19         Income Taxes                                        HTML     76K 
29: R20         Derivative Financial Instruments                    HTML    157K 
30: R21         Accumulated Other Comprehensive Loss                HTML    280K 
31: R22         Contingencies                                       HTML     41K 
32: R23         Discontinued Operations                             HTML    357K 
33: R24         Business Segments                                   HTML    142K 
34: R25         Supplemental Disclosures                            HTML     66K 
35: R26         Basis of Presentation and Significant Accounting    HTML     69K 
                Policies (Policies)                                              
36: R27         Revenue from Contracts with Customers (Tables)      HTML    202K 
37: R28         Accounts Receivable (Tables)                        HTML     54K 
38: R29         Leases (Tables)                                     HTML    135K 
39: R30         Business Combinations and Divestitures (Tables)     HTML     76K 
40: R31         Fair Value Measurements and Long-term Investments   HTML    181K 
                (Tables)                                                         
41: R32         Stockholders' Equity (Tables)                       HTML    139K 
42: R33         Earnings (Loss) Per Share (Tables)                  HTML    233K 
43: R34         Goodwill and Intangible Assets (Tables)             HTML    165K 
44: R35         Debt (Tables)                                       HTML    159K 
45: R36         Income Taxes (Tables)                               HTML     63K 
46: R37         Derivative Financial Instruments (Tables)           HTML    153K 
47: R38         Accumulated Other Comprehensive Loss (Tables)       HTML    280K 
48: R39         Discontinued Operations (Tables)                    HTML    356K 
49: R40         Business Segments (Tables)                          HTML    133K 
50: R41         Supplemental Disclosures (Tables)                   HTML     65K 
51: R42         Basis of Presentation and Significant Accounting    HTML     69K 
                Policies - Additional Information (Detail)                       
52: R43         Revenue from Contracts with Customers - Additional  HTML     45K 
                Information (Detail)                                             
53: R44         Revenue from Contracts with Customers - Summary of  HTML     44K 
                Revenue Recognized on Various Performance                        
                Obligations and Elected Accounting Expedients                    
                (Detail)                                                         
54: R45         Revenue from Contracts with Customers - Summary of  HTML     54K 
                Revenue by Type and Nature of Revenue Stream by                  
                Reportable Segments (Detail)                                     
55: R46         Revenue from Contracts with Customers - Summary of  HTML     40K 
                Changes in Estimate of Credit Losses for Contract                
                Assets (Details)                                                 
56: R47         Accounts Receivable - Schedule of Changes in        HTML     38K 
                Estimate of Credit Losses for Trade Accounts                     
                Receivable (Detail)                                              
57: R48         Leases - Additional Information (Detail)            HTML     37K 
58: R49         Leases - Summary of Operating Costs Associated      HTML     37K 
                with Leased Assets (Detail)                                      
59: R50         Leases - Supplemental Cash Flow Information for     HTML     34K 
                Operating Leases (Detail)                                        
60: R51         Leases - Summary of Balance Sheet Location and      HTML     40K 
                Balances for Operating Leases (Detail)                           
61: R52         Leases - Summary of Future Maturities of Lease and  HTML     51K 
                Non-Lease Components (Detail)                                    
62: R53         Business Combinations and Divestitures -            HTML     91K 
                Additional Information (Detail)                                  
63: R54         Business Combinations and Divestitures - Schedule   HTML     53K 
                of Assets Acquired and Liabilities Assumed                       
                (Detail)                                                         
64: R55         Business Combinations and Divestitures - Schedule   HTML     42K 
                of Acquired Intangible Assets Amortization                       
                (Detail)                                                         
65: R56         Fair Value Measurements and Long-term Investments   HTML     59K 
                - Summary of Financial Assets and Liabilities                    
                Measured at Fair Value on Recurring Basis (Detail)               
66: R57         Fair Value Measurements and Long-term Investments   HTML     37K 
                - Summary of Changes in Liability Measured at Fair               
                Value on Recurring Basis (Detail)                                
67: R58         Fair Value Measurements and Long-term Investments   HTML     48K 
                - Summary of Long-term Equity Investments Included               
                in Other Assets (Detail)                                         
68: R59         Fair Value Measurements and Long-term Investments   HTML     41K 
                - Additional Information (Detail)                                
69: R60         Stockholders' Equity - Additional Information       HTML     66K 
                (Detail)                                                         
70: R61         Stockholders' Equity - Stock-Based Compensation     HTML     44K 
                Expense (Detail)                                                 
71: R62         Stockholders' Equity - Stock-Based Awards Granted   HTML     43K 
                (Detail)                                                         
72: R63         Earnings (Loss) Per Share - Calculations of         HTML     98K 
                Earnings (Loss) Per Share (Detail)                               
73: R64         Earnings (Loss) Per Share - Anti-Dilutive Stock     HTML     32K 
                Options, Restricted Stock Unit Awards and Warrants               
                Excluded from Computation of Diluted Earnings                    
                (Loss) Per Share (Detail)                                        
74: R65         Goodwill and Intangible Assets - Goodwill and       HTML     50K 
                Intangible Assets (Detail)                                       
75: R66         Goodwill and Intangible Assets - Changes in         HTML     42K 
                Carrying Amount of Goodwill (Detail)                             
76: R67         Goodwill and Intangible Assets - Additional         HTML     32K 
                Information (Detail)                                             
77: R68         Debt - Debt Outstanding Excluding Lease             HTML     43K 
                Obligations (Detail)                                             
78: R69         Debt - Debt Outstanding Excluding Lease             HTML     43K 
                Obligations (Parenthetical) (Detail)                             
79: R70         Debt - Interest Expense (Detail)                    HTML     41K 
80: R71         Debt - Interest Expense Related to 0.875%           HTML     40K 
                Convertible Senior Notes (Detail)                                
81: R72         Debt - Additional Information (Detail)              HTML    100K 
82: R73         Debt - Summary of Future Debt Payment Obligations   HTML     54K 
                (Detail)                                                         
83: R74         Debt - Summary of Future Debt Payment Obligations   HTML     33K 
                (Parenthetical) (Detail)                                         
84: R75         Income Taxes - Effective Tax Rates (Detail)         HTML     41K 
85: R76         Income Taxes - Additional Information (Detail)      HTML     45K 
86: R77         Derivative Financial Instruments - Fair Value and   HTML     43K 
                Balance Sheet Locations (Detail)                                 
87: R78         Derivative Financial Instruments - Additional       HTML     45K 
                Information (Detail)                                             
88: R79         Derivative Financial Instruments - Derivatives      HTML     45K 
                Instruments Designated as Cash Flow Hedges                       
                (Detail)                                                         
89: R80         Accumulated Other Comprehensive Loss - Components   HTML     66K 
                of Accumulated Other Comprehensive Loss (Detail)                 
90: R81         Accumulated Other Comprehensive Loss - Components   HTML     33K 
                of Accumulated Other Comprehensive Loss                          
                (Parenthetical) (Detail)                                         
91: R82         Accumulated Other Comprehensive Loss - Income Tax   HTML     79K 
                Effects Related to Components of Other                           
                Comprehensive Income (Loss) (Detail)                             
92: R83         Contingencies - Additional Information (Detail)     HTML     47K 
93: R84         Discontinued Operations - Additional Information    HTML     36K 
                (Detail)                                                         
94: R85         Discontinued Operations - Summary of Major Classes  HTML    117K 
                of Assets and Liabilities as Reported on                         
                Consolidated Balance Sheets (Detail)                             
95: R86         Discontinued Operations - Summary of Major Classes  HTML     37K 
                of Assets and Liabilities as Reported on                         
                Consolidated Balance Sheets (Parenthetical)                      
                (Detail)                                                         
96: R87         Discontinued Operations - Summary of Major Income   HTML     90K 
                and Expense Line Items Reported in Consolidated                  
                Statements of Operations (Detail)                                
97: R88         Business Segments - Additional Information          HTML     35K 
                (Detail)                                                         
98: R89         Business Segments - Revenues and Income (Loss)      HTML     53K 
                from Operations Related to Segment Within                        
                Reconciliation to Consolidated Amounts (Detail)                  
99: R90         Supplemental Disclosures - Supplemental             HTML     43K 
                Disclosures (Detail)                                             
102: XML         IDEA XML File -- Filing Summary                      XML    201K  
100: XML         XBRL Instance -- mdrx-20220630_htm                   XML   5.50M  
101: EXCEL       IDEA Workbook of Financial Reports                  XLSX    190K  
 7: EX-101.CAL  XBRL Calculations -- mdrx-20220630_cal               XML    281K 
 5: EX-101.DEF  XBRL Definitions -- mdrx-20220630_def                XML   1.01M 
 8: EX-101.LAB  XBRL Labels -- mdrx-20220630_lab                     XML   1.83M 
 9: EX-101.PRE  XBRL Presentations -- mdrx-20220630_pre              XML   1.45M 
 6: EX-101.SCH  XBRL Schema -- mdrx-20220630                         XSD    257K 
103: JSON        XBRL Instance as JSON Data -- MetaLinks              569±   936K  
104: ZIP         XBRL Zipped Folder -- 0000950170-22-015497-xbrl      Zip    473K  


‘R2’   —   Consolidated Balance Sheets (Unaudited)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.22.2
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Current assets:    
Cash and cash equivalents $ 500,164 $ 132,517
Restricted cash 1,307 1,308
Accounts receivable, net of allowance of $12,581 and $13,360 as of June 30, 2022 and December 31, 2021, respectively 166,746 171,622
Contract assets, net of allowance of $564 and $576 as of June 30, 2022 and December 31, 2021 49,029 63,429
Prepaid expenses and other current assets 91,521 60,511
Assets held for sale 20,000 331,955
Total current assets attributable to discontinued operations 828,767 761,342
Fixed assets, net 14,971 9,819
Software development costs, net 82,541 74,688
Intangible assets, net 149,210 149,690
Goodwill 524,149 506,607
Deferred taxes, net 7 0
Contract assets - long-term, net of allowance of $1,201 and $1,534 as of June 30 2022 and December 31, 2021, respectively 19,358 28,174
Right-of-use assets - operating leases 15,904 18,324
Other assets 79,309 83,429
Long-term assets attributable to discontinued operations 0 793,156
Total assets 1,714,216 2,425,229
Current liabilities:    
Accounts payable 18,014 5,281
Accrued expenses 82,964 54,518
Accrued compensation and benefits 34,001 31,055
Deferred revenue 84,882 120,748
Current operating lease liabilities 6,095 6,133
Current liabilities attributable to discontinued operations 30,372 329,347
Total current liabilities attributable to discontinued operations 256,328 547,082
Long-term debt 199,895 350,062
Deferred revenue 2,021 1,839
Deferred taxes, net 10,861 16,625
Long-term operating lease liabilities 13,873 16,754
Other liabilities 34,890 33,823
Long-term liabilities attributable to discontinued operations 0 50,906
Total liabilities 517,868 1,017,091
Commitments and contingencies
Stockholders’ equity:    
Preferred stock: $0.01 par value, 1,000 shares authorized, no shares issued and outstanding as of June 30, 2022 and December 31, 2021 0 0
Common stock: $0.01 par value, 349,000 shares authorized as of June 30, 2022 and December 31, 2021; 279,175 and 110,793 shares issued and outstanding as of June 30, 2022, respectively; 276,705 and 116,114 shares issued and outstanding as of December 31, 2021, respectively 2,790 2,766
Treasury stock: at cost, 168,383 and 160,591 shares as of June 30, 2022 and December 31, 2021, respectively (1,465,177) (1,321,805)
Additional paid-in capital 1,923,805 1,962,386
Retained earnings 738,864 767,556
Accumulated other comprehensive loss (3,934) (2,765)
Total stockholders’ equity 1,196,348 1,408,138
Total liabilities and stockholders’ equity $ 1,714,216 $ 2,425,229

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/8/22
For Period end:6/30/22
12/31/2110-K,  10-K/A,  5
 List all Filings 


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/05/22  Veradigm Inc.                     8-K:2,5,9   5/02/22   13:2.1M                                   Donnelley … Solutions/FA
Top
Filing Submission 0000950170-22-015497   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 3:08:58.1pm ET